InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Arsenault Kaitlyn. Director active across 1 company, notably Skye Bioscience, Inc.. In total, 7 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €207k. History available since 25 August 2023. The latest transaction was disclosed on 15 November 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
ARSENAULT KAITLYN is Chief Financial Officer at Skye Bioscience, Inc. The record shows 7 filings in total. Across the 7 sampled filings, they cover the period from 2023-08-29 to 2025-02-28, with EUR 0 of buys and EUR 206676 of sells, and the modal transaction nature is Attribution.